lymphedema treatment act 2017
lymphedema treatment act 2017 The Lymphedema Treatment Act marked a major step in healthcare policy. Introduced in 2017, this bipartisan effort aimed to improve care for those with chronic swelling conditions. It sought to expand Medicare coverage for essential therapies, like compression garments.
Rep. David Reichert led the bill with strong support—385 cosponsors from both parties. Though it didn’t pass initially, it set the stage for future progress. Advocates worked tirelessly to push for better coverage and awareness.
lymphedema treatment act 2017 This law highlights the importance of accessible care for chronic conditions. By addressing gaps in insurance, it helps patients manage symptoms effectively. The effort reflects how policy and advocacy can shape better health outcomes.
What Was the Lymphedema Treatment Act 2017?
Heather Ferguson’s advocacy work laid the foundation for this critical healthcare bill. Her son’s diagnosis inspired a 13-year campaign to improve access to essential therapies. The effort culminated in Rep. David Reichert introducing the legislation in 2017.
Legislative Origins and Sponsorship
Rep. Reichert, a Republican from Washington, spearheaded the bill with rare bipartisan backing. Over 385 cosponsors joined, reflecting broad recognition of the issue. The proposal aimed to amend the Social Security Act to classify compression garments as durable medical equipment. lymphedema treatment act 2017
lymphedema treatment act 2017 Before this, Medicare coverage only included pumps and limited therapies. Patients faced high out-of-pocket costs for compression supplies. The bill sought to close this gap, ensuring comprehensive care for chronic swelling conditions.
Key Goals of the Bill
The legislation’s language explicitly targeted “Medicare coverage of certain lymphedema compression treatment items.” It aimed to reduce financial burdens while standardizing care nationwide.
Though the 2017 version didn’t pass, it set benchmarks for the 2022 success. Differences included refined eligibility criteria and expanded item lists. Advocates credit the 115th Congress for laying crucial groundwork.
Provisions of the Lymphedema Treatment Act
New coverage rules under the legislation brought significant relief to those managing chronic swelling. The 2024 updates standardized Medicare coverage for essential compression garments, reducing financial strain for patients. Below, we break down key provisions.
Medicare Coverage for Compression Supplies
Patients now qualify for:
- 3 daytime garments per affected body part every 6 months
- 2 nighttime garments every 2 years
- Unlimited bandages and accessories
Custom-fit items require clinical notes proving medical necessity. Standard-fit options follow simpler approval processes.
Eligibility and Covered Items
The policy applies to both primary and secondary cases. Healthcare providers must document:
- Diagnosis details
- Body measurements for custom garments
- Therapy plans
Pumps and surgeries remain under existing benefit categories. CMS updated billing codes to streamline claims.
Why the 2017 Bill Didn’t Pass—And What Changed Later
lymphedema treatment act 2017 Despite strong bipartisan support, the 2017 legislation stalled before reaching a full vote. The 115th Congress faced gridlock on healthcare reforms, leaving many bills like this one stuck in committee. Even with 385 cosponsors, competing priorities and session deadlines halted progress.
Challenges in the 115th Congress
Lawmakers struggled to advance standalone healthcare proposals during this session. The bill’s narrow focus on Medicare coverage made it vulnerable to delays. Advocates noted that complex policies often need broader legislative vehicles to become law.
How Advocacy Efforts Paved the Way for 2024 Implementation
Grassroots campaigns turned setbacks into momentum. Key steps included:
- Heather Ferguson mobilizing 100,000+ advocate contacts to Congress
- Strategic inclusion in the 2022 omnibus spending package
- Educational sessions for providers on new coverage rules
By 2021, reintroduced legislation (S.1315) gained traction. Persistent advocacy ensured its final passage in 2022. lymphedema treatment act 2017
The Lasting Influence of the Lymphedema Treatment Act
Beyond Medicare, the ripple effects of this policy are reshaping care standards. Private insurers and state Medicaid programs now mirror its coverage compression rules, easing costs for patients. Studies project an 85% drop in infections when using proper compression therapy—saving $15,000 per avoided hospitalization.
The O&P industry expanded custom garments production to meet demand. Yet hurdles remain, like inconsistent billing codes and providers needing training on new rules.
Advocates push to widen coverage compression limits and close state gaps. Heather Ferguson urges patients to lead outreach, ensuring insurers honor these vital supplies. The fight for accessible compression therapy continues, proving policy changes spark lasting change.